These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, Zhao WF, Yang ZH, Zhong CY, Li GZ. Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549 [Abstract] [Full Text] [Related]
3. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. Vilanova JC, Barceló-Vidal C, Comet J, Boada M, Barceló J, Ferrer J, Albanell J. AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259 [Abstract] [Full Text] [Related]
11. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps. Sung YS, Kwon HJ, Park BW, Cho G, Lee CK, Cho KS, Kim JK. AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504 [Abstract] [Full Text] [Related]
17. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection. Gholizadeh N, Greer PB, Simpson J, Goodwin J, Fu C, Lau P, Siddique S, Heerschap A, Ramadan S. J Biomed Sci; 2021 Jul 19; 28(1):54. PubMed ID: 34281540 [Abstract] [Full Text] [Related]